Nifty 16912.25 (-1.65%)
Sensex 56747.14 (-1.65%)
Nifty Bank 35735.9 (-1.27%)
Nifty IT 34879.4 (-2.70%)
Nifty Financial Services 17596.7 (-1.03%)
Adani Ports 723.45 (-1.90%)
Asian Paints 3038.30 (-2.32%)
Axis Bank 663.10 (-1.47%)
B P C L 383.45 (-0.63%)
Bajaj Auto 3249.75 (-1.16%)
Bajaj Finance 6951.75 (-1.66%)
Bajaj Finserv 16893.45 (-3.40%)
Bharti Airtel 697.60 (-2.89%)
Britannia Inds. 3496.20 (-1.62%)
Cipla 894.95 (-1.87%)
Coal India 148.55 (-7.01%)
Divis Lab. 4646.80 (-2.32%)
Dr Reddys Labs 4498.70 (-2.13%)
Eicher Motors 2444.10 (-0.47%)
Grasim Inds 1660.75 (-2.53%)
H D F C 2768.80 (-0.10%)
HCL Technologies 1136.55 (-2.98%)
HDFC Bank 1503.80 (-0.64%)
HDFC Life Insur. 684.20 (-0.98%)
Hero Motocorp 2420.00 (-1.72%)
Hind. Unilever 2306.50 (-1.59%)
Hindalco Inds. 421.35 (-0.78%)
I O C L 120.95 (-1.02%)
ICICI Bank 709.55 (-0.94%)
IndusInd Bank 915.65 (-3.73%)
Infosys 1695.30 (-2.32%)
ITC 217.90 (-1.69%)
JSW Steel 642.85 (-0.26%)
Kotak Mah. Bank 1885.20 (-1.51%)
Larsen & Toubro 1782.65 (-1.03%)
M & M 822.15 (-1.77%)
Maruti Suzuki 7042.85 (-2.30%)
Nestle India 19016.50 (-1.58%)
NTPC 124.35 (-2.09%)
O N G C 143.35 (-1.75%)
Power Grid Corpn 202.00 (-1.99%)
Reliance Industr 2362.60 (-1.90%)
SBI Life Insuran 1148.50 (-1.50%)
Shree Cement 25612.35 (-1.16%)
St Bk of India 465.30 (-1.66%)
Sun Pharma.Inds. 737.15 (-1.95%)
Tata Consumer 747.60 (-3.45%)
Tata Motors 467.20 (-2.69%)
Tata Steel 1108.80 (-0.82%)
TCS 3536.40 (-2.86%)
Tech Mahindra 1551.75 (-2.61%)
Titan Company 2325.30 (-1.86%)
UltraTech Cem. 7214.60 (-1.61%)
UPL 716.55 (0.53%)
Wipro 624.50 (-2.54%)
JBCHEPHARM

J B Chemicals & Pharmaceu..

₹1583.
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

  • Master Rating:
  • Jb Chemicals & Pha.(Nse) has an operating revenue of Rs. 2,275.67 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 29% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 147 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

As per analysts rating in the last 6 months, the recommendation isHOLD J B Chem & Pharm

J B Chemicals & Pharmaceuticals Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

J B Chemicals & Pharmaceuticals Ltd Synopsis

NSE-Medical-Diversified

J B Chemicals & Phar is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1892.00 Cr. and Equity Capital is Rs. 15.46 Cr. for the Year ended 31/03/2021. J B Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/1976 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24390MH1976PLC019380 and registration number is 019380.
  • Market Cap

    INR 12,217.51 Cr

  • Sales

    INR 2,063.62 Cr

  • Shares in Float

    3.40 Cr

  • No of Funds

    209 K

  • Yield

    1.02%

  • Book Value

    6.91

  • U/D Vol Ratio

    0.9

  • LTDebt/Equity

    %

  • Alpha

    0.18

  • Beta

    0.33

J B Chemicals & Pharmaceuticals Ltd Ownership
J B Chemicals & Pharmaceuticals Ltd Management

J B Chemicals & Pharmaceuticals Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 1806.46091445.29081484.56231453.38811387.8613
Fixed Assets Annual Cr 590.1706599.374567.2009587.31612.4527
Total Non Current Assets Annual Cr 742.4878805.7444805.5688781.2632941.3611
Total Current Assets Annual Cr 1457.94141005.2696986.5466985.3928743.0116
Total Assets Annual Cr 2200.42921811.0141792.11541766.6561684.3727
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 233.7492187.015185.0232173.9126163.6242
ROE Annual % 24.7418.5512.268.812.46
ROCE Annual % 31.7423.2117.4812.0315.51
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 35.3225.4521.861922.36

J B Chemicals & Pharmaceuticals Ltd Technicals

EMA & SMA

CURRENT PRICE

1583 (-1.98)

    • Bullish Moving Averages 2
    • Bearish Moving Averages 14

EMA

  • 20 Day

    1638.62

  • 50 Day

    1682.32

  • 100 Day

    1667.2

  • 200 Day

    1556.76

J B Chemicals & Pharmaceuticals Ltd Resistance and support

1606.65 PIVOT

  • First Resistance

    1633.3

  • Second Resistance

    1651.65

  • Third Resistance

    1678.3

  • First Support

    1588.3

  • Second Support

    1561.65

  • Third Support

    1543.3

  • RSI

    39.52

  • MFI

    40.88

  • MACD

    -29.8

  • MACD signal line

    -28.52

J B Chemicals & Pharmaceuticals Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 26,011 1,192,084 45.83%
Week 55,422 2,755,048 49.71%
1 Month 93,086 4,877,683 52.4%
6 Month 158,598 8,006,011 50.48%

J B Chemicals & Pharmaceuticals Ltd Price change analysis

-74.15

Over 1 month

Low High
1538 1769.9

-182.85

Over 3 month

Low High
1432 1985

70.75

Over 6 months

Low High
1432 1985

588.75

Over Year

Low High
956.05 1985

Similar Stocks

News

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement u

Audio recording of Earnings conference call Read More

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement

Earnings conference call Transcript Read More

Earnings Call for Q2FY22 of J B Chemicals & Pharmaceuticals

Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings Read More

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement u

Newspaper cutting of extract of consolidated financial results for quarter ended on September 30, 2021 Read More

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement

Press Release Read More

Blogs

FAQs

Stock Directory-

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All 0-9